Signed three-year framework agreement with Hamad Bin Khalifa University for quantum computing collaboration with on-cloud system access and regional installation, demonstrating international expansion and ecosystem development.
Insiders sold $33.8 million with zero buying activity. The 183.3 P/S ratio is extremely elevated, and insider behavior suggests lack of confidence in the company's near-term prospects.
Mixed signals: strong revenue growth ($5.6M vs $61K YoY) and substantial backlog ($42.5M) are offset by significant operating losses ($11.8M net loss), expenses 3.5X revenues, and 114% YoY expense growth. Strong cash position ($1.3B) provides flexibility but profitability remains uncertain. Zacks rates it Hold.
Despite 91x revenue growth YoY, the company remains unprofitable with gross losses, 114% operating expense surge, and high integration risks from $180M in acquisitions. Stock down 47.9% over past year and trades at expensive 34.61X forward P/S versus industry median of 4.09X. Loss per share estimates have worsened over past 30 days.
While the company shows some positive momentum with 82.8% revenue growth and recent commercial wins, it remains significantly smaller and faces substantial scaling challenges. The high valuation multiple and operational risks make it less attractive than IonQ, though not fundamentally negative.
While the company shows impressive 82.8% YoY revenue growth and zero debt, it faces significant risks including early-stage commercial adoption, heavy dependence on government contracts (70-80% of revenue), intense competition from IBM, and unpredictable revenue streams. The analyst does not recommend it due to technology immaturity.
The company shows concerning fundamentals heading into earnings: minimal organic revenue growth ($3.7M mostly from acquisitions), significant operating losses ($19.8M expenses), low manufacturing utilization at Fab 1, and integration challenges from recent acquisitions. Despite a large cash balance, the lack of clear commercial progress and scaling of quantum products creates high risk of disappointing Q2 results relative to investor expectations.
Stock gained 5.8% on positive sentiment from AT&T's quantum computing strategy announcement, though the company wasn't directly involved in the deal. Analysts forecast 10x revenue growth, but execution risk remains high given limited major contracts to date.
The company is under investigation for potential breaches of fiduciary duties by officers and directors involving self-dealing, which raises serious corporate governance concerns and legal liability risks for shareholders.
Listed as a competitor in the quantum computing race with no specific commentary; subject to the same cash runway and dilution risk concerns mentioned for all quantum stocks.
Executed $110M acquisition of Luminar Semiconductor, Q1 revenue surged 9364% to $3.69M, following same vertical integration playbook as IonQ, benefits from federal government backing and defense sector demand, though carries higher short interest (32.6%) creating volatility.
Smallest pure-play quantum company at $1.67B market cap, most vulnerable to being marginalized by Quantinuum's entry and potential sector consolidation around larger players.
Despite a 44% stock surge in three days, the company was excluded from the $2 billion grant program and must continue burning $42+ million annually without government support, making the stock appreciation unsustainable and illogical.
Stock surged 19.35% in regular trading and 5.78% in after-hours trading following broad sector enthusiasm from the $2 billion quantum computing funding announcement, despite QUBT not being explicitly named as a direct recipient.
Receiving funding as part of the $2 billion quantum computing investment; shares climbed 13.49% in pre-market trading
Company beat both earnings and revenue estimates, demonstrated significant year-over-year revenue growth (from $39k to $3.69M), made strategic acquisitions to drive growth, and stock price surged 16.40% following results announcement. CEO commentary highlights operational progress and market demand for their photonic solutions.
Strong revenue growth (94x increase YoY), successful strategic acquisitions expanding product portfolio and manufacturing capabilities, solid cash position of $1.4 billion, and growing commercial momentum with contract backlog of $16 million. Despite net loss in Q1, the operational progress and strategic positioning in high-growth quantum and photonics markets support positive outlook.
While NeuraWave launch is commercially promising and revenue is growing, the stock remains volatile and down significantly over six months. The company faces intense competition from established players, profitability is far off, and the analyst recommends waiting for earnings results before investing. The sentiment reflects both opportunity and substantial risk.
Stock is up on the week as part of broad quantum computing sector momentum following Nvidia announcement and favorable S&P Global report.
Stock up 12.70% on news that Nvidia's Ising model could accelerate its path to profitability from 2029 to potentially earlier, addressing its current cash burn of $37 million annually.
Partnered with Ciena to showcase time-frequency entanglement-based quantum key distribution technology integrated with quantum-safe communications platform, demonstrating commercial viability of quantum security solutions.
Photonic chip technology operates at room temperature without delicate lasers, offering manufacturing advantages. Expected sales surge once mass production begins. Smallest market cap ($1.7B) of the three with potential for significant upside, though currently unprofitable with negative gross margin.
Strong revenue growth (219% YoY), significant capital raise ($750M), strategic acquisition of Luminar Semiconductor, substantial asset growth ($1.6B), improved net loss position, and operational progress with Fab 1 facility contributing revenue. CEO confirmation and new product launches (Neurawave) demonstrate forward momentum.
Despite a 9% stock price increase, the article highlights severe overvaluation concerns. With a P/S ratio of 3,600x compared to IQM's 51.4x, and only $546,000 in annual revenue against a $1.8B market cap, the stock appears fundamentally disconnected from reality. The analyst explicitly states the stock should be declining, not rising.
Similar risks as peers; early-stage commercialization with unproven economics vulnerable to displacement by well-funded competitors.
Articles that tag QUBT but are mainly about other companies.
Signed a three-year Framework Agreement with Hamad Bin Khalifa University to collaborate on quantum computing, sensing, and communications, expanding market presence in the Middle East and establishing institutional partnerships for practical quantum solutions.
Stock edged down 1.43% as part of the broader sector rotation away from existing quantum plays.
Up 14.98% on quantum computing sector momentum from government investment announcement
29% rally is considered a bubble indicator. Extreme P/S ratio of 2,333 is highly unsustainable. Author warns of barrier-to-entry risks from well-funded competitors.
Stock up 12.70% as a quantum computing player that could leverage Nvidia's Ising AI to improve performance and accelerate path to profitability in the growing quantum market.
Stock up 14.30% as part of sector-wide gains driven by improved quantum error correction technology and increased government/industry investment in quantum computing
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
